Note: Ingredients listed on restricted chemical lists
EC/CAS
1317-33-5
Name of the chemical
molybdenum disulphide
Concentration
1-5
EC/CAS
14807-96-6
Name of the chemical
Talc
Concentration
1-5
General Information
Version
5
Revision date
2026-02-04
Product name
504TS2FB10
1.2.1 Relevant identified uses
Industrial applications
Manufacturer Name
PPG Industries, Inc
Emergency telephone
1-888-774-2001
Icons in SDS
Company Information
company name
PPG Industries, Inc
GHS Information
Signal word
Danger
Hazard Codes
Hazard statements (CLP)
H317, H350
Hazard statements
Code
Statements
H317
May cause an allergic skin reaction
Section 2
SECTION 2: Hazards identification
Ingredient(s) with unknown acute toxicity
9.1% (oral), 14.8% (dermal), 10.8% (inhalation)
Signal word
Danger
Hazard statements
May cause cancer.
Prevention
Obtain special instructions before use. Do not handle until all safety precautions have been read and understood. Wear protective gloves, protective clothing and eye or face protection.
Response
IF exposed or concerned: Get medical advice or attention.
Storage
Store locked up.
Disposal
Dispose of contents and container in accordance with all local, regional, national and international regulations.
Supplemental label elements
Contains isothiazolinones. May cause allergic reaction. Emits toxic fumes when heated. Hazards identified when used : Photosensitive agents : In case of accidental eye contact, avoid direct exposure to the sun or other sources of UV light as severe irritation including burns may result. These reactions can be delayed – get medical attention if pain, irritation or blistering occurs after contact. In case of accidental skin contact, avoid direct exposure to the sun or other sources of UV light as severe irritation including burns may result. These reactions can be delayed – get medical attention if pain, irritation, rash or blistering occurs after contact.
2.3 Other hazards
None known.
2.1 Classification of the substance or mixture
Percentage of the mixture consisting of ingredient(s) of unknown acute toxicity: 9.1% (oral), 14.8% (dermal), 10.8% (inhalation)